v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities:    
Net loss $ (710,571) $ (408,133)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 50,371 45,970
Stock compensation expense 111,660 81,708
Changes in operating assets and liabilities:    
Accounts receivable (4,923) (4,838)
Prepaid expenses and other current assets 103,736 217,677
Intangible assets (12,500)
Accounts payable 110,741 66,441
Accrued compensation and benefits 10,946 (43,197)
Accrued liabilities 11,272 (10,535)
Operating lease liabilities (47,062) (40,187)
Net cash used in operating activities (363,830) (107,594)
Cash flows from investing activities:    
Net cash used in investing activities
Cash flows from financing activities:    
Payments on short term insurance financing (86,997) (90,278)
Net cash used in financing activities (86,997) (90,278)
Effects of exchange rates on cash (1,864)
Net decrease in cash, cash equivalents and restricted cash (452,691) (197,872)
Cash and cash equivalents and restricted cash at beginning of period 833,539 1,612,915
Cash and cash equivalents and restricted cash at end of period 380,848 1,415,043
Supplemental disclosure of cash flow information    
Cash paid for interest $ 995 $ 3,238